OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial
Yuemei Hu, Zhaofeng Bi, Ya Zheng, et al.
Science Bulletin (2023) Vol. 68, Iss. 20, pp. 2448-2455
Open Access | Times Cited: 8
Yuemei Hu, Zhaofeng Bi, Ya Zheng, et al.
Science Bulletin (2023) Vol. 68, Iss. 20, pp. 2448-2455
Open Access | Times Cited: 8
Showing 8 citing articles:
Prevalence and genotype distribution of human papillomavirus among women with cervical or vaginal lesions in Jiangsu, China: 2 cross-sectional studies (2012–2013 and 2020–2021)
Weiwei Han, Wen‐Juan Wang, Kai Chu, et al.
Oncology and Translational Medicine (2025)
Open Access
Weiwei Han, Wen‐Juan Wang, Kai Chu, et al.
Oncology and Translational Medicine (2025)
Open Access
Long-term protective efficacy of the Escherichia coli-produced HPV-16/18 bivalent human papillomavirus vaccine in women vaccinated at 18–45 years: a 9-year follow-up study
Xinhua Jia, Shangying Hu, Xuefeng Kuang, et al.
Infectious Medicine (2025), pp. 100164-100164
Open Access
Xinhua Jia, Shangying Hu, Xuefeng Kuang, et al.
Infectious Medicine (2025), pp. 100164-100164
Open Access
Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use
Yu Zhang, Ke Qiu, Jianjun Ren, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Yu Zhang, Ke Qiu, Jianjun Ren, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
HPV and Cervical Cancer—Biology, Prevention, and Treatment Updates
Emilia Włoszek, Katherine Krupa, Eliza Skrok, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 122-122
Open Access
Emilia Włoszek, Katherine Krupa, Eliza Skrok, et al.
Current Oncology (2025) Vol. 32, Iss. 3, pp. 122-122
Open Access
Safety Assessment of Concurrent Vaccination with the HPV Vaccine and the COVID-19 Vaccine in Fujian Province, China: A Retrospective Study
Yan Zhang, Yuhang Zhang, Binhua Dong, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 673-673
Open Access
Yan Zhang, Yuhang Zhang, Binhua Dong, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 673-673
Open Access
Prokaryote- and Eukaryote-Based Expression Systems: Advances in Post-Pandemic Viral Antigen Production for Vaccines
Nelli S. Khudainazarova, Dmitriy L. Granovskiy, О. А. Кондакова, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11979-11979
Open Access
Nelli S. Khudainazarova, Dmitriy L. Granovskiy, О. А. Кондакова, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11979-11979
Open Access
The variations in the natural history of high‐risk human papillomavirus infections in Chinese healthy women aged 27–45 years compared with 18–26 years: A prospective cohort study
Qi Chen, Xingmei Yao, Jiali Quan, et al.
International Journal of Cancer (2024) Vol. 156, Iss. 5, pp. 1043-1054
Closed Access
Qi Chen, Xingmei Yao, Jiali Quan, et al.
International Journal of Cancer (2024) Vol. 156, Iss. 5, pp. 1043-1054
Closed Access
Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatus
Kongxin Zhu, Mengjun Liao, Lu Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Kongxin Zhu, Mengjun Liao, Lu Chen, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
